2,654
edits
(changed Clinical Trial Professional and Technical Fee Billing to Clinical Research and Clinical Trial Professional and Technical Fee Billing so link would be bold and black when on the page) |
No edit summary |
||
(8 intermediate revisions by 2 users not shown) | |||
Line 19: | Line 19: | ||
</table> | </table> | ||
<br /> | <br /> | ||
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[International | [[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[Disclosing Foreign Support and International Activities]] | [[Health Care Vendor Interactions]] | [[Credit Hour Definition]] | [[Whistleblower]]<br /> | ||
<br /><br /> | <br /> | ||
Policy No.: '''8008'''<br /> | Policy No.: '''8008'''<br /> | ||
Effective Date: ''' 08/23/18'''<br /> | Effective Date: ''' 08/23/18'''<br /> | ||
Revised Date: <br /> | Revised Date: <br /> | ||
Reviewed Date: <br /> | Reviewed Date: '''07/29/21'''<br /> | ||
<br /> | <br /> | ||
<big>'''Clinical Research and Clinical Trial Professional and Technical Fee Billing Policy</big>''' | <big>'''Clinical Research and Clinical Trial Professional and Technical Fee Billing Policy</big>''' | ||
Line 79: | Line 79: | ||
==Additional Information== | ==Additional Information== | ||
*Contact the [mailto:sarah.glodencarlson@unmc.edu Chief Compliance Officer] | *Contact the [mailto:sarah.glodencarlson@unmc.edu Chief Compliance Officer] | ||
*[https://www.unmc.edu/academicaffairs/_documents/compliance/ | *[https://www.unmc.edu/academicaffairs/_documents/compliance/wiki/Clinical_Trial_Professional_and_Technical_Fee_Billing_Procedures.pdf Clinical Trial Professional and Technical Fee Billing Procedures] | ||
*[https://www.unmc.edu/academicaffairs/_documents/compliance/MedicareQualifyingClinicalTrialsFlowsheet1.pdf Medicare Qualifying Clinical Trials Flowchart] | *[https://www.unmc.edu/academicaffairs/_documents/compliance/MedicareQualifyingClinicalTrialsFlowsheet1.pdf Medicare Qualifying Clinical Trials Flowchart] | ||
*[https://www.unmc.edu/academicaffairs/_documents/compliance/ABNRequirementsFlowchart.pdf Advanced Beneficiary Notice Requirements Flowchart] | *[https://www.unmc.edu/academicaffairs/_documents/compliance/ABNRequirementsFlowchart.pdf Advanced Beneficiary Notice Requirements Flowchart] | ||
*Nebraska Medicine Policy IM10, [ | *Nebraska Medicine Policy IM10, [https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_IM10_OneChartTraining.pdf One Chart Training Classes] | ||
*Nebraska Medicine IM41, [ | *Nebraska Medicine IM41, [https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_IM41_OneChartResearchDocumentation.pdf One Chart Research Documentation] | ||
*Nebraska Medicine [https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_2015-Tip-Sheet-Looking-Up-Grant-Charges-on-Statements.pdf One Chart Tips and Tricks Sheet] - Looking Up Grant Charges on Statements | *Nebraska Medicine [https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_2015-Tip-Sheet-Looking-Up-Grant-Charges-on-Statements.pdf One Chart Tips and Tricks Sheet] - Looking Up Grant Charges on Statements | ||
*Nebraska Medicine Policy MI15, [ | *Nebraska Medicine Policy MI15, [https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_MI15_AdvancedBeneficiaryNoticeABN.pdf Advanced Beneficiary Notice (ABN)] | ||
*Nebraska Medicine Policy MI19, [ | *Nebraska Medicine Policy MI19, [https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_MI19_ResearchBillingProcess.pdf Research Billing Process] | ||
*Nebraska Medicine Policy MI29, [ | *Nebraska Medicine Policy MI29, [https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_MI29_InvestigationalDevices.pdf Investigational Devices] | ||
*Nebraska Medicine Policy RI06, [ | *Nebraska Medicine Policy RI06, [https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_RI06_AdmissionRegistrationtoNebraskaMedicine.pdf Admission/Registration to Nebraska Medicine] | ||
*[https://www.unmc.edu/academicaffairs/_documents/compliance/NE_Medicine_FNC-201_Financial_Clinical_Trial_Insurance_Preauthorization_Insured_and_NonInsured.pdf Nebraska Medicine Policy FNC-201, Financial Clinical Trial Insurance Preauthorization Insured and Noninsured] (unmc.edu) | |||
*[https://www.unmc.edu/academicaffairs/_documents/compliance/Clinical_Trial_Insurance_Predetermination_Request_Form.pdf Clinical Trial Insurance Predetermination Request] Form | *[https://www.unmc.edu/academicaffairs/_documents/compliance/Clinical_Trial_Insurance_Predetermination_Request_Form.pdf Clinical Trial Insurance Predetermination Request] Form | ||
*Nebraska Medicine [ | *Nebraska Medicine [https://www.unmc.edu/academicaffairs/_documents/compliance/ACCESS-REGSP-110.pdf Nebraska Medicine ACCESS-REGSP-110] | ||
* [https://grants.nih.gov/policy/clinical-trials/definition.htm National Institutes of Health] | * [https://grants.nih.gov/policy/clinical-trials/definition.htm National Institutes of Health] | ||
This page maintained by [mailto:dpanowic@unmc.edu dkp]. | This page maintained by [mailto:dpanowic@unmc.edu dkp]. |